CN Patent

CN112334134A — 氨氯地平制剂

Assigned to Silvergate Pharmaceuticals Inc · Expires 2021-02-05 · 5y expired

What this patent protects

本文提供了稳定的氨氯地平液体制剂。本文还提供了使用氨氯地平液体制剂治疗包括高血压和冠状动脉疾病(CAD)在内的某些疾病的方法。

USPTO Abstract

本文提供了稳定的氨氯地平液体制剂。本文还提供了使用氨氯地平液体制剂治疗包括高血压和冠状动脉疾病(CAD)在内的某些疾病的方法。

Drugs covered by this patent

amlodipine-benzoate (AMLODIPINE BENZOATE)

Patent Metadata

Patent number: CN112334134A
Jurisdiction: CN
Classification: —
Expires: 2021-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Silvergate Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.